Ainsley A. Culbert

Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription

Matthew P. Coghlan, Ainsley A. Culbert, Darren A.E. Cross et al. · Chemistry & Biology · 2000 · 895 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +11

Selective small-molecule inhibitors of glycogen synthase kinase-3 activity protect primary neurones from death

Darren A.E. Cross, Ainsley A. Culbert, Katy Chalmers et al. · Journal of Neurochemistry · 2001 · 366 citations

Life Sciences, Biochemistry, Neuroscience +17

Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial

Martin Dennis, Gillian Mead, John Forbes et al. · The Lancet · 2018 · 286 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

The Structure of Phosphorylated GSK-3β Complexed with a Peptide, FRATtide, that Inhibits β-Catenin Phosphorylation

B.D. Bax, Paul S. Carter, Ceri Lewis et al. · Structure · 2001 · 199 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +9

MAPK-activated Protein Kinase 2 Deficiency in Microglia Inhibits Pro-inflammatory Mediator Release and Resultant Neurotoxicity

Ainsley A. Culbert, Stephen D. Skaper, David Howlett et al. · Journal of Biological Chemistry · 2006 · 170 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17